Liberated Solutions, Inc. Satisfies Substantial Convertible Debt
CHESTER, N.Y., June 27, 2018 (GLOBE NEWSWIRE) -- Liberated Solutions, Inc.(OTC PINK:LIBE) is pleased to announce it has issued an 8-K stating that Power Up Lending Group, Ltd has converted all its convertible promissory notes eligible for conversion and those convertible promissory notes are now deemed satisfied by the Company.
All remaining convertible promissory notes held by the Investor are not currently eligible for conversion and will not be eligible for conversion until at least 180 days following the issuance date of the respective convertible promissory note. The Company has the right to prepay each convertible promissory note in cash pursuant to the terms of each convertible promissory note if it elects to do so.
“In short, this was a big hurdle to cross before moving ahead with our projects, specifically AIG and Sterling.” Stated Brian Conway, CEO of Liberated Solutions, Inc. “We’re pursuing the structuring of these opportunities to include the repayment of our remaining debt.”
About Liberated Solutions, Inc.
Liberated Solutions, Inc. is a diversified green energy services holding company delivering conventional as well as non-conventional Eco-friendly solutions throughout North America. For its customers, Liberated operations in Real Estate, Alternative Energy, Technology, and Lifestyle projects. For its shareholders, Liberated Solutions operates and acquires a diverse array of energy products and service companies with proven revenues and operations. Its mission is to be the best small cap environmental services company of its kind in North America.
Safe Harbor for Forward-Looking Statements: This press release may contain forward-looking information. There are many factors that could cause the Company's expectations and beliefs about its operations, its services and service offerings, its results to fail to materialize. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements.
Contact Information
Contact:
Brian Conway
CEO
Liberated Solutions, Inc.
Phone: (845) 610-3817
© 2018 GlobeNewswire, Inc. All Rights Reserved.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
